Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference51 articles.
1. Deininger MWN, Goldman JM, Melo JV: The molecular biology of chronic myeloid leukemia. Blood 2000, 96:3343–3356.
2. Bocchia M, Wentworth PA, Southwood S, et al.: Specific binding of leukemia oncogene fusion protein peptides to HLA Class I molecules. Blood 1995, 85:2680–2684.
3. Greco G, Fruci D, Accapezzato D, et al.: Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia 1996, 10:693–699.
4. Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, et al.: Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses. Haematologica 2005, 90:1324–1332.
5. Clark RE, Dodi IA, Hill SC, et al.: Direct evidence that leukaemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 2001, 98:2887–2893.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献